Standout Papers
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy (2011)
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy (2011)
- Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis (2002)
- Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease (2015)
- Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction (2006)
- Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude (2003)
- 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary (2011)
- Left Ventricular Remodeling in Heart Failure (2011)
- Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2 (2002)
- Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance (2008)
- Relationship Between Infarct Size and Outcomes Following Primary PCI (2016)
- Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial (2013)
- High-Risk Plaque Detected on Coronary CT Angiography Predicts Acute Coronary Syndromes Independent of Significant Stenosis in Acute Chest Pain (2014)
- Use of High-Risk Coronary Atherosclerotic Plaque Detection for Risk Stratification of Patients With Stable Chest Pain (2018)
- Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis (2015)
- Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain (2017)
- Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment (2020)
Immediate Impact
2 by Nobel laureates 5 from Science/Nature 120 standout
Citing Papers
Heart Failure With Preserved Ejection Fraction
2023 Standout
Diagnosis and Treatment of Acute Myocarditis
2023 Standout
Works of James E. Udelson being referenced
Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction
2020
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 5: Valvular Heart Disease
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| James E. Udelson | 19494 | 6724 | 5404 | 318 | 25.2k | |
| Anthony N. DeMaria | 17928 | 8243 | 8553 | 455 | 26.0k | |
| Tatiana Kuznetsova | 20383 | 5392 | 4119 | 273 | 26.4k | |
| Sherif F. Nagueh | 27565 | 10362 | 4591 | 238 | 31.1k | |
| Otto A. Smiseth | 26278 | 10213 | 4539 | 235 | 29.3k | |
| Thor Edvardsen | 21464 | 9469 | 4688 | 376 | 24.6k | |
| Nathaniel Reichek | 23126 | 8604 | 4489 | 219 | 27.5k | |
| Allan L. Klein | 19220 | 6029 | 3270 | 414 | 22.3k | |
| Martin St. John Sutton | 18250 | 4573 | 3802 | 159 | 21.3k | |
| David O. Hodge | 12547 | 8785 | 4056 | 632 | 26.3k | |
| Paul Grayburn | 18668 | 5084 | 7187 | 361 | 23.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...